Potential Benefits and Product Highlights

Brings multiple actives together around recovery, tissue-support and inflammatory-signaling pathways.
Convenient alternative to purchasing each component separately.
Component-specific chemistry and testing make the formula easier to compare.
Useful for customers who prefer a coordinated stack with one clearly documented product profile.
Independent third-party testing with lot-specific quality documentation.

Product Details

Product name	BPC-157 10 mg + TB-500 10 mg Peptide Blend
Main category	Stacks & Blends
Subcategory	Peptide Blends
Product format	Lyophilized vial
Declared strength	20 mg total
Active identity / composition	BPC-157, TB-500
Quality documentation	Independent third-party testing and lot-specific Certificate of Analysis

Chemical Information

Compound	Amount	Molecular formula	Molecular weight	Sequence / structure
BPC-157	10 mg	C₆₂H₉₈N₁₆O₂₂	1419.5 g/mol	Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
TB-500	10 mg	C₃₈H₆₈N₁₀O₁₄	889.0 g/mol	Ac-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln (Ac-LKKTETQ)

Chemical nomenclature note: TB-500 nomenclature is frequently confused with full-length thymosin beta-4. In analytical literature, TB-500 is identified as the N-acetylated seven-residue fragment Ac-LKKTETQ with a molecular weight of about 889.0 g/mol. Full-length thymosin beta-4 is a separate 43-amino-acid molecule with formula C₂₁₂H₃₅₀N₅₆O₇₈S and a molecular weight of about 4,963.4 g/mol. This page uses the fragment-specific TB-500 identity.

How It Works

This is a combination product, not a new single molecule. Each component retains its own structure, target and time course, creating a broader multi-pathway profile than a single-ingredient option.

KLOW 80mg shares one or more core ingredients to Wolverine stack while offering a different component balance or product format.

Evidence note: Potential benefits depend on the evidence for each component and should not be interpreted as proof that combining ingredients produces additive or synergistic results. Sources: PubChem. BPC-157 compound record; PubChem. TB-500 compound record; Sikiric P. et al. – review of experimental BPC-157 research; PubChem. Thymosin beta-4 compound record.

Product Strength and Usage Information

This lyophilized vial is offered with a stated strength of 20 mg total. Check the current label, serving or unit information and lot-specific documentation before use.

No single dosage suits every compound, goal or customer. Use should follow the product label and appropriate professional guidance, especially for potent hormones, prescription-class ingredients and investigational compounds.

Quality and Testing

Identity, purity and finished-product content are reviewed as separate quality attributes. The lot-specific Certificate of Analysis should identify the methods, results, batch number, testing provider and test date.

Chromatographic testing evaluates purity and related substances.
Mass spectrometry supports molecular identity and expected mass.
Finished-product testing evaluates the supplied concentration, unit content, fill, count, uniformity or physical presentation as applicable.
Lot-specific documentation supports confident purchasing and product traceability.

Storage and Handling

Keep the sealed vial under the temperature conditions printed on the product label.
Protect from light, moisture and repeated temperature changes.
After reconstitution, follow the stated refrigeration and use-period instructions.
Avoid repeated freeze-thaw cycles and inspect the vial before use.

Frequently Asked Questions

What is included in this product?

BPC-157 10 mg + TB-500 10 mg Peptide Blend supplied in a lyophilized vial with the declared composition and strength shown in the specifications.

What is BPC-157 10 mg + TB-500 10 mg Peptide Blend?

BPC-157 10 mg + TB-500 10 mg Peptide Blend combines clearly identified components for customers interested in recovery, tissue-support and inflammatory-signaling pathways.

What potential benefits are associated with it?

Potential areas of interest include brings multiple actives together around recovery, tissue-support and inflammatory-signaling pathways, convenient alternative to purchasing each component separately, component-specific chemistry and testing make the formula easier to compare.

How does it work?

This is a combination product, not a new single molecule. Each component retains its own structure, target and time course, creating a broader multi-pathway profile than a single-ingredient option.

How strong is the evidence?

Potential benefits depend on the evidence for each component and should not be interpreted as proof that combining ingredients produces additive or synergistic results.

How is product quality documented?

Independent third-party testing and a lot-specific Certificate of Analysis provide identity, purity and finished-product information.

How should the product be stored?

Keep the product in its original container and follow the temperature, light and handling conditions shown on the label.

What should be checked when the product arrives?

Review the product name, format, strength, lot number, container integrity and matching Certificate of Analysis.